|drug1673||Interferon Beta-1B Wiki||0.58|
|drug3168||Standard Care Wiki||0.50|
|drug1672||Interferon Beta-1A Wiki||0.50|
There is one clinical trial.
The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) has been discovered recently in December 2019 from wuhan city in China to spread in more than 40 countries allover the world. This disease has gain the attention of all nations after it has been stated as a pandemic by the World Health Organization (WHO) in March 12, 2020. Currently no treatment has been proved to be efficient in the treatment of infected patients by COVID-19. Natural honey has been demonstrated as potent antimicrobial in many research investigations and has been considered a good alternative for antiviral drugs for the treatment of some viral infections. The investigators aim to study the efficacy of natural honey in the treatment of COVID-19 patients in this randomized , multicenter, controlled trial, comparing honey in one arm to standard care in the other arm.
Description: Percentage of patients turned from positive to negative swaps at day 14Measure: Rate of recovery from positive to negative swaps Time: 14 days
Description: Number of days till no feverMeasure: Fever to normal temperature in days Time: 14 days
Description: Number of days till lungs recovery in chest X ray or CTMeasure: Resolution of lung inflammation in CT or X ray Time: 30 days
Description: mortality rate in each group at 30 daysMeasure: 30 days mortality rate Time: 30 days
Description: Number of days from initiation of intervention till changing of the swap test result from positive to negativeMeasure: Number of days till reaching negative swab results Time: 30 days
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports